Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. BioElectronics Corporation (BIEL) Message Board

Looking forward to inked deals and the 10-Q result

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 8402
(Total Views: 673)
Posted On: 02/10/2020 6:46:41 PM
Avatar
Posted By: Atlas1
Looking forward to inked deals and the 10-Q results from this latest quarter. Moving forward, BIEL turns profitable. Let go of the past and focus on the future. BIEL has finally turned the corner!

I want to share an excellent post from Srinsocal over on IFLUB. Srin posts are all well researched and written and I applaud him on his due diligence. This one should help clarify any questions you may have regarding the recent FDA clearance.

Atlas1



Much Confusion Regarding FDA Device Approval/Clearance

Some would like us to believe that ActiPatch is an inferior Device because it used the 510k Process rather that the Pre Market Approval Process to get FDA Authorization to Market.

From the site referenced in post:

"Clearance: When a medical device is cleared, this means it has undergone a 510(k) submission, which FDA has reviewed and provided clearance."

"Approval: For Class III medical devices to be legally marketed they must undergo a rigorous review and approval process. Following a successful submission of a premarket approval (PMA) or a Humanitarian Device Exemption (HDE), the device is given Approval by FDA."

Notice that this website considers the 'Approval Process' to be for Class III Medical Devices which are things like Heart Pacemakers and other devices that support of sustain life.

ActiPatch is a Class II Medical Device. All of the Class II Devices are given Authorization to Market through the 510k Process unless there is not a similar Device already on the Market, a Predicate Device. 95-98% of Medical Devices use the 510k Process.

One of the major differences between the 510K and the PMA Processes is Clinical Studies. 510Ks generally don't need them, PMA's always need them.

BIEL submitted 3 Clinical Studies to support their Full Body Musculoskeletal 510K. The FDA accepted all 3 Studies and found that in all 3"The results indicate that ActiPatch significantly reduced pain".

So BIEL has gone beyond what 95% of the Medical Devices on the Market have done, in providing 3 Clinical Studies to prove efficacy, and as such is superior to the average Medical Device.


(2)
(0)




BioElectronics Corporation (BIEL) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us